FAKTOR-OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000SV12N53

Delayed Deutsche Boerse AG 11:39:34 20/06/2024 BST
3.99 EUR -0.25% Intraday chart for FAKTOR-OPTIONSSCHEIN - STRYKER CORP.
Current month-10.91%
1 month-13.23%
Date Price Change
20/06/24 3.99 -0.25%
19/06/24 4 -3.38%
18/06/24 4.14 -3.27%
17/06/24 4.28 -1.38%
14/06/24 4.34 +0.23%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 11:39 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SV12N5
ISINDE000SV12N53
Date issued 15/03/2023
Strike 267.2 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.73
Lowest since issue 3.68
Spread 0.15
Spread %3.62%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus